US Patent Issued to Syngap Research Fund on Sept. 23 for "Methods for treating neurodevelopmental disorders via administration of organic tricyclic compounds" (Minnesota, California, Washington, Texas Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,419,845, issued on Sept. 23, was assigned to Syngap Research Fund (San Diego).

"Methods for treating neurodevelopmental disorders via administration of organic tricyclic compounds" was invented by Marta Dahiya (Arlington, Texas), Mike Graglia (Mill Valley, Calif.), Drishti Guin (Oakland, Calif.), Kathryn Helde (Seattle), Chris Moxham (Palo Alto, Calif.), Sabine Topka (Mountain View, Calif.) and Lindsay Wieczorek (Chaska, Minn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of treatment of neurodevelopmental disorders via administration of organic tricyclic compounds are described. Organic tricyclic compounds administered in the method of the in...